Undisclosed Vaccine Enhancement Program

About Qrono

Qrono Inc. is a preclinical-stage biotech leveraging antigen-presenting cell (APC) biology to create novel immunotherapies for vaccines and autoimmune diseases. The company is developing a targeted delivery platform aimed at precisely instructing the immune system, potentially leading to more effective and durable treatments. Headquartered in Pittsburgh, Pennsylvania, Qrono appears to be a small, research-focused private company in the early stages of technology validation and asset development. Its success hinges on translating its APC-targeting platform into viable therapeutic candidates.

Therapeutic Areas

Other Infectious Disease (unspecified) Drugs